Mitra, D., Armijo, G. K., Ober, E. H., Baker, S. M., Turner, H. C., & Broustas, C. G. (2025). MIIST305 mitigates gastrointestinal acute radiation syndrome injury and ameliorates radiation-induced gut microbiome dysbiosis. Gut Microbes, 17(1). https://doi.org/10.1080/19490976.2025.2458189

Park, H., Lynch, E., Tillman, A., Lewis, K., Jin, Z., Uhlemann, A.-C., Abrams, J. A., & Freedberg, D. E. (2025). A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis. Critical Care, 29(1). https://doi.org/10.1186/s13054-024-05232-3

Gao, F., Shen, Y., Wu, H., Laue, H. E., Lau, F. K., Gillet, V., Lai, Y., Shrubsole, M. J., Prada, D., Zhang, W., Liu, Z., Bellenger, J.-P., Takser, L., & Baccarelli, A. A. (2024). Associations of Stool Metal Exposures with Childhood Gut Microbiome Multiomics Profiles in a Prospective Birth Cohort Study. Environmental Science & Technology, 58(50), 22053–22063. https://doi.org/10.1021/acs.est.4c09642

Kato, R., Yamamoto, T., Ogata, H., Miyata, K., Hayashi, S., Gershon, M. D., & Kadowaki, M. (2024). Indigenous gut microbiota constitutively drive release of ciliary neurotrophic factor from mucosal enteric glia to maintain the homeostasis of enteric neural circuits. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1372670

Yuzefpolskaya, M., Bohn, B., Ladanyi, A., Pinsino, A., Braghieri, L., Carey, M. R., Clerkin, K., Sayer, G. T., Latif, F., Koji, T., Uriel, N., Nandakumar, R., Uhlemann, A.-C., Colombo, P. C., & Demmer, R. T. (2024). Alterations in the sarcopenia index are associated with inflammation, gut, and oral microbiota among heart failure, left ventricular assist device, and heart transplant patients. The Journal of Heart and Lung Transplantation, 43(9), 1395–1408. https://doi.org/10.1016/j.healun.2024.04.069

Chen, X., Zhang, J., Yin, N., Wele, P., Li, F., Dave, S., Lin, J., Xiao, H., & Wu, X. (2023). Resveratrol in disease prevention and health promotion: A role of the gut microbiome. Critical Reviews in Food Science and Nutrition, 64(17), 5878–5895. https://doi.org/10.1080/10408398.2022.2159921

Shishani, R., Wang, A., Lyo, V., Nandakumar, R., & Cummings, B. P. (2024). Vertical Sleeve Gastrectomy Reduces Gut Luminal Deoxycholic Acid Concentrations in Mice. Obesity Surgery, 34(7), 2483–2491. https://doi.org/10.1007/s11695-024-07288-0

Reuter, M. A., Tucker, M., Marfori, Z., Shishani, R., Bustamante, J. M., Moreno, R., Goodson, M. L., Ehrlich, A., Taha, A. Y., Lein, P. J., Joshi, N., Brito, I., Durbin-Johnson, B., Nandakumar, R., & Cummings, B. P. (2024). Dietary resistant starch supplementation increases gut luminal deoxycholic acid abundance in mice. Gut Microbes, 16(1). https://doi.org/10.1080/19490976.2024.2315632

Weh, K. M., Howard, C. L., Zhang, Y., Tripp, B. A., Clarke, J. L., Howell, A. B., Rubenstein, J. H., Abrams, J. A., Westerhoff, M., & Kresty, L. A. (2024). Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome. JCI Insight. https://doi.org/10.1172/jci.insight.168112

Sung, C., Park, C. G., Maienschein-Cline, M., Chlipala, G., Green, S., Doorenbos, A., Fink, A., Bronas, U., & Lockwood, M. (2024). Associations Between Gut Microbial Features and Sickness Symptoms in Kidney Transplant Recipients. Biological Research For Nursing, 26(3), 368–379. https://doi.org/10.1177/10998004241227560

Xu, H., Wang, T., Miao, Y., Qian, M., Yang, Y., & Wang, S. (2024). MK-BMC: a Multi-Kernel framework with Boosted distance metrics for Microbiome data for Classification. Bioinformatics, 40(1). https://doi.org/10.1093/bioinformatics/btad757

Cui, W., Guo, M., Liu, D., Xiao, P., Yang, C., Huang, H., Liang, C., Yang, Y., Fu, X., Zhang, Y., Liu, J., Shi, S., Cong, J., Han, Z., Xu, Y., Du, L., Yin, C., Zhang, Y., Sun, J., … Chu, B. (2024). Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition. Nature Cell Biology, 26(1), 124–137. https://doi.org/10.1038/s41556-023-01314-6

Yong, G. J. M., Porsche, C. E., Sitarik, A. R., Fujimura, K. E., McCauley, K., Nguyen, D. T., Levin, A. M., Woodcroft, K. J., Ownby, D. R., Rundle, A. G., Johnson, C. C., Cassidy-Bushrow, A., & Lynch, S. V. (2023). Precocious infant fecal microbiome promotes enterocyte barrier dysfuction, altered neuroendocrine signaling and associates with increased childhood obesity risk. Gut Microbes, 16(1). https://doi.org/10.1080/19490976.2023.2290661

Liang, X., Zhang, Z., Wang, H., Lu, X., Li, W., Lu, H., Roy, A., Shen, X., Irwin, D. M., & Shen, Y. (2023). Early-life prophylactic antibiotic treatment disturbs the stability of the gut microbiota and increases susceptibility to H9N2 AIV in chicks. Microbiome, 11(1). https://doi.org/10.1186/s40168-023-01609-8

Brockmann, L., Tran, A., Huang, Y., Edwards, M., Ronda, C., Wang, H. H., & Ivanov, I. I. (2023). Intestinal microbiota-specific Th17 cells possess regulatory properties and suppress effector T cells via c-MAF and IL-10. Immunity, 56(12), 2719-2735.e7. https://doi.org/10.1016/j.immuni.2023.11.003

Huang, Z., Li, Y., Park, H., Ho, M., Bhardwaj, K., Sugimura, N., Lee, H. W., Meng, H., Ebert, M. P., Chao, K., Burgermeister, E., Bhatt, A. P., Shetty, S. A., Li, K., Wen, W., & Zuo, T. (2023). Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization. Gut Microbes, 15(1). https://doi.org/10.1080/19490976.2023.2237645

Zhang, Y., Shen, Y., Liufu, N., Liu, L., Li, W., Shi, Z., Zheng, H., Mei, X., Chen, C.-Y., Jiang, Z., Abtahi, S., Dong, Y., Liang, F., Shi, Y., Cheng, L. L., Yang, G., Kang, J. X., Wilkinson, J. E., & Xie, Z. (2023). Transmission of Alzheimer’s disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients. Molecular Psychiatry, 28(10), 4421–4437. https://doi.org/10.1038/s41380-023-02216-7

Baldwin-Hunter, B. L., Rozenberg, F. D., Annavajhala, M. K., Park, H., DiMango, E. A., Keating, C. L., Uhlemann, A.-C., & Abrams, J. A. (2023). The gut microbiome, short chain fatty acids, and related metabolites in cystic fibrosis patients with and without colonic adenomas. Journal of Cystic Fibrosis, 22(4), 738–744. https://doi.org/10.1016/j.jcf.2023.01.013

Sumida, K., Pierre, J. F., Yuzefpolskaya, M., Colombo, P. C., Demmer, R. T., & Kovesdy, C. P. (2023). Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease. Seminars in Nephrology, 43(2), 151408. https://doi.org/10.1016/j.semnephrol.2023.151408

Yuzefpolskaya, M., Bohn, B., Ladanyi, A., Khoruts, A., Colombo, P. C., & Demmer, R. T. (2023). Oral and gut microbiome alterations in heart failure: Epidemiology, pathogenesis and response to advanced heart failure therapies. The Journal of Heart and Lung Transplantation, 42(3), 291–300. https://doi.org/10.1016/j.healun.2022.12.009

Guo, C., Che, X., Briese, T., Ranjan, A., Allicock, O., Yates, R. A., Cheng, A., March, D., Hornig, M., Komaroff, A. L., Levine, S., Bateman, L., Vernon, S. D., Klimas, N. G., Montoya, J. G., Peterson, D. L., Lipkin, W. I., & Williams, B. L. (2023). Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS. Cell Host & Microbe, 31(2), 288-304.e8. https://doi.org/10.1016/j.chom.2023.01.004

Dang, J. T., Mocanu, V., Park, H., Laffin, M., Hotte, N., Karmali, S., Birch, D. W., & Madsen, K. L. (2022). Roux-en-Y gastric bypass and sleeve gastrectomy induce substantial and persistent changes in microbial communities and metabolic pathways. Gut Microbes, 14(1). https://doi.org/10.1080/19490976.2022.2050636

Campana, A. M., Laue, H. E., Shen, Y., Shrubsole, M. J., & Baccarelli, A. A. (2022). Assessing the role of the gut microbiome at the interface between environmental chemical exposures and human health: Current knowledge and challenges. Environmental Pollution, 315, 120380. https://doi.org/10.1016/j.envpol.2022.120380

Cheng, X., Zhang, Y., Li, Y., Wu, Q., Wu, J., Park, S.-K., Guo, C., & Lu, J. (2022). Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases. BMC Microbiology, 22(1). https://doi.org/10.1186/s12866-022-02686-9

Blackett, J. W., Sun, Y., Purpura, L., Margolis, K. G., Elkind, M. S. V., O’Byrne, S., Wainberg, M., Abrams, J. A., Wang, H. H., Chang, L., & Freedberg, D. E. (2022). DECREASED GUT MICROBIOME TRYPTOPHAN METABOLISM AND SEROTONERGIC SIGNALING IN PATIENTS WITH PERSISTENT MENTAL HEALTH AND GASTROINTESTINAL SYMPTOMS AFTER COVID-19. Clinical and Translational Gastroenterology. https://doi.org/10.14309/ctg.0000000000000524

Laue, H. E., Shen, Y., Bloomquist, T. R., Wu, H., Brennan, K. J. M., Cassoulet, R., Wilkie, E., Gillet, V., Desautels, A.-S., Abdelouahab, N., Bellenger, J. P., Burris, H. H., Coull, B. A., Weisskopf, M. G., Zhang, W., Takser, L., & Baccarelli, A. A. (2022). In Utero Exposure to Caffeine and Acetaminophen, the Gut Microbiome, and Neurodevelopmental Outcomes: A Prospective Birth Cohort Study. International Journal of Environmental Research and Public Health, 19(15), 9357. https://doi.org/10.3390/ijerph19159357

Sumida, K., Han, Z., Chiu, C.-Y., Mims, T. S., Bajwa, A., Demmer, R. T., Datta, S., Kovesdy, C. P., & Pierre, J. F. (2022). Circulating Microbiota in Cardiometabolic Disease. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.892232

Yao, M., Fei, Y., Zhang, S., Qiu, B., Zhu, L., Li, F., Berglund, B., Xiao, H., & Li, L. (2022). Gut Microbiota Composition in Relation to the Metabolism of Oral Administrated Resveratrol. Nutrients, 14(5), 1013. https://doi.org/10.3390/nu14051013

Dreisbach, C., Morgan, H., Cochran, C., Gyamfi, A., Henderson, W. A., & Prescott, S. (2022). Metabolic and Microbial Changes Associated With Diet and Obesity During Pregnancy: What Can We Learn From Animal Studies? Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.795924

Freedberg, D. E., Richardson, M., Nattakom, M., Cheung, J., Lynch, E., Zachariah, P., & Wang, H. H. (2022). Are There Bad ICU Rooms? Temporal Relationship between Patient and ICU Room Microbiome, and Influence on Vancomycin-Resistant Enterococcus Colonization. MSphere, 7(1). https://doi.org/10.1128/msphere.01007-21

Shen, Y., Laue, H. E., Shrubsole, M. J., Wu, H., Bloomquist, T. R., Larouche, A., Zhao, K., Gao, F., Boivin, A., Prada, D., Hunting, D. J., Gillet, V., Takser, L., & Baccarelli, A. A. (2022). Associations of Childhood and Perinatal Blood Metals with Children’s Gut Microbiomes in a Canadian Gestation Cohort. Environmental Health Perspectives, 130(1). https://doi.org/10.1289/ehp9674